Innovator IBD 50 ETF (NYSEARCA:FFTY) Stock Short Interest Falls 67.4%

Innovator IBD 50 ETF (NYSEARCA:FFTY) was the recipient of a significant decrease in short interest in September. As of September 30th, there was short interest totaling 8,533 shares, a decrease of 67.4% from the September 15th total of 26,201 shares. Based on an average daily trading volume, of 8,524 shares, the days-to-cover ratio is currently 1.0 days. Currently, 0.4% of the shares of the stock are sold short.

Institutional Trading of Innovator IBD 50 ETF

Hedge funds and other institutional investors have recently bought and sold shares of the company. Kraematon Investment Advisors Inc. purchased a new position in shares of Innovator IBD 50 ETF during the 2nd quarter valued at $1,021,000. Guardian Wealth Advisors LLC NC purchased a new stake in Innovator IBD 50 ETF in the second quarter valued at approximately $507,000. Royal Bank of Canada raised its position in shares of Innovator IBD 50 ETF by 3,222.5% during the 1st quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after buying an additional 17,724 shares in the last quarter. Concurrent Investment Advisors LLC raised its position in Innovator IBD 50 ETF by 11.1% during the second quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after purchasing an additional 6,321 shares in the last quarter. Finally, Trail Ridge Investment Advisors LLC purchased a new position in shares of Innovator IBD 50 ETF during the 2nd quarter valued at about $210,000.

Innovator IBD 50 ETF Trading Down 0.6%

Shares of Innovator IBD 50 ETF stock traded down $0.20 on Tuesday, reaching $35.15. The stock had a trading volume of 2,679 shares, compared to its average volume of 51,266. The business’s 50 day moving average is $36.02 and its two-hundred day moving average is $37.94. Innovator IBD 50 ETF has a 1 year low of $31.61 and a 1 year high of $44.08. The company has a market cap of $68.54 million, a P/E ratio of 30.34 and a beta of 1.48.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.